SLC27A2 antibody (AA 30-200)

Catalog No. ABIN7175432

Product Details anti-SLC27A2 Antibody

Target: SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))

Binding Specificity: AA 30-200

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SLC27A2 antibody is un-conjugated

Application: ELISA

Cross-Reactivity: Human

Purification: Antigen Affinity Purified

Immunogen: Recombinant Human Very long-chain acyl-CoA synthetase protein (30-200AA)

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for SLC27A2

Target: SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))

Alternative Name: SLC27A2 (SLC27A2 Products)

Synonyms: vlcs antibody, fatp2 antibody, vlacs antibody, acsvl1 antibody, facvl1 antibody, im:7139614 antibody, slc27a2 antibody, wu:fb99g05 antibody, zgc:112376 antibody, ACSVL1 antibody, FACVL1 antibody, HsT17226 antibody, hFACVL1 antibody, FATP2 antibody, VLCS antibody, Vlac antibody, Vlacs antibody, VLACS antibody, solute carrier family 27 (fatty acid transporter), member 2 L homeolog antibody, solute carrier family 27 member 2 antibody, solute carrier family 27 (fatty acid transporter), member 2a antibody, solute carrier family 27 (fatty acid transporter), member 2 antibody, slc27a2.L antibody, SLC27A2 antibody, slc27a2a antibody, slc27a2 antibody, Slc27a2 antibody

Background:

Background: Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precurors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes (By similarity).

Aliases: ACSVL1 antibody, FACVL1 antibody, FATP 2 antibody, FATP-2 antibody, FATP2 antibody, Fatty acid coenzyme A ligase, very long chain 1 antibody, Fatty acid transport protein 2 antibody, Fatty-acid-coenzyme A ligase antibody, hFACVL1 antibody, HsT17226 antibody, Long chain fatty acid CoA ligase antibody, Long-chain-fatty-acid--CoA ligase antibody, S27A2_HUMAN antibody, Slc27a2 antibody, Solute carrier family 27 (fatty acid transporter), member 2 antibody, Solute carrier family 27 member 2 antibody, THCA CoA ligase antibody, THCA-CoA ligase antibody, Very long chain acyl CoA synthetase antibody, Very long chain fatty acid CoA ligase antibody, Very long chain fatty acid coenzyme A ligase 1 antibody, very long-chain 1 antibody, Very long-chain acyl-CoA synthetase antibody, Very long-chain-fatty-acid-CoA ligase antibody, VLACS antibody, VLCS antibody

UniProt: O14975

Pathways: Monocarboxylic Acid Catabolic Process, SARS-CoV-2 Protein Interactome